Similarly in CRC models, higher expression of YTHDF1 recognizes m6A modified PD-L1 and VISTA to enhance their stability, thus serving as the ideal target to promote the infiltration of CD8+ T cells, when synergizing with PD-1 blockade [134]. The gene discussed is CD8A; the disease is colorectal carcinoma.